Lataa...
Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Oncolytic virotherapy with mutants derived from Herpes simplex virus (HSV) type 1 exhibit significant antitumor effects in preclinical models. Several mutants have now been tested in clinical trials for a variety of cancer types, and all have been found to be safe. While there have been hints of ant...
Tallennettuna:
| Julkaisussa: | Curr Pharm Biotechnol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4233127/ https://ncbi.nlm.nih.gov/pubmed/21740359 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|